| Bioactivity | TLR7 agonist 28 (compound 3) is a potent TLR7 agonist. TLR7 agonist 28 can conjugat to antitumor monoclonal antibodies (mAbs) for cancer immunotherapy[1]. |
| CAS | 1801518-98-8 |
| Formula | C26H25N9O7 |
| Molar Mass | 575.53 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gadd AJ, et al. Targeted Activation of Toll-Like Receptors: Conjugation of a Toll-Like Receptor 7 Agonist to a Monoclonal Antibody Maintains Antigen Binding and Specificity. Bioconjug Chem. 2015 Aug 19;26(8):1743-52. |
TLR7 agonist 28
CAS: 1801518-98-8 F: C26H25N9O7 W: 575.53
TLR7 agonist 28 (compound 3) is a potent TLR7 agonist. TLR7 agonist 28 can conjugat to antitumor monoclonal antibodies (
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.